Omeros Corp - Company Profile

Powered by

All the sales intelligence you need on Omeros Corp in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Omeros Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Omeros Corp.

Back to companies

Omeros Corp: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Omeros Corp patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP4275752A2 Application Behandlung von erkrankungen im zusammenhang mit sucht und impulskontrolle mittels pde7-inhibitoren A61K31/00; A61K31/045; A61K31/085; A61K31/122; A61K31/135; A61K31/137; A61K31/195; A61K31/197; A61K31/216; A61K31/222; A61K31/337; A61K31/357; A61K31/381; A61K31/385; A61K31/4015; A61K31/4025; A61K31/4162; A61K31/4178; A61K31/4188; A61K31/42; A61K31/433; A61K31/435; A61K31/437; A61K31/44; A61K31/4409; A61K31/443; A61K31/4439; A61K31/454; A61K31/485; A61K31/496; A61K31/4985; A61K31/505; A61K31/506; A61K31/517; A61K31/519; A61K31/52; A61K31/527; A61K31/53; A61K31/5377; A61K31/5383; A61K31/541; A61K31/542; A61K31/55; A61K31/551; A61K31/554; A61K45/00; A61P25/00; A61P25/08; A61P25/18; A61P25/22; A61P25/24; A61P25/30; A61P25/32; A61P25/34; A61P25/36; A61P43/00 November 15, 2023
CA2875567C Grant Compositions and methods of inhibiting masp-1 and/or masp-2 and/or masp-3 for the treatment of various diseases and disorders A61K2039/505; A61K39/3955; A61K45/06; A61P1/00; A61P1/16; A61P11/00; A61P11/06; A61P13/12; A61P17/02; A61P19/02; A61P27/02; A61P29/00; A61P31/00; A61P31/04; A61P31/10; A61P31/12; A61P33/00; A61P33/14; A61P35/00; A61P37/06; A61P39/02; A61P43/00; A61P7/00; A61P7/02; C07K16/18; C07K16/40; C07K2317/21; C07K2317/31; C07K2317/33; C07K2317/622; C07K2317/76; C07K2317/92 November 14, 2023
EP4119577A3 Search Report Zusammensetzungen und verfahren zur hemmung von masp-1 und/oder masp-2 und/oder masp-3 zur behandlung verschiedener erkrankungen und störungen A61K2039/505; A61K39/3955; A61K45/06; A61P1/00; A61P1/16; A61P11/00; A61P11/06; A61P13/12; A61P17/02; A61P19/02; A61P27/02; A61P29/00; A61P31/00; A61P31/04; A61P31/10; A61P31/12; A61P33/00; A61P33/14; A61P35/00; A61P37/06; A61P39/02; A61P43/00; A61P7/00; A61P7/02; C07K16/18; C07K16/40; C07K2317/21; C07K2317/31; C07K2317/33; C07K2317/622; C07K2317/76; C07K2317/92 November 08, 2023
US11807641B2 Grant Masp-2 inhibitors and methods of use C07D207/16; C07D211/60; C07D401/06; C07D401/10; C07D401/12; C07D401/14; C07D403/12; C07D409/04; C07D409/14; C07D413/12; C07D413/14; C07D417/12; C07D471/04; C07D487/04; C07D495/04; C07F9/65583; C07F9/6561 November 07, 2023
AU2020277135B2 Grant Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods A61K2039/545; A61K39/3955; A61K47/12; A61K47/183; A61K47/26; A61K9/0019; A61K9/08; A61P13/12; A61P25/00; A61P25/02; A61P25/14; A61P25/16; A61P25/26; A61P25/28; A61P27/02; A61P35/00; A61P7/02; A61P7/06; C07K16/40; C07K2317/53; C07K2317/94 November 02, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer